{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:03:04Z","timestamp":1792094584152,"version":"4.4.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:00:00Z","timestamp":1570924800000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["DK067555"],"award-info":[{"award-number":["DK067555"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jaut.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:57:47Z","timestamp":1534208267000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Interferon alpha: The key trigger of type 1 diabetes"],"prefix":"10.1016","volume":"94","author":[{"given":"Angela","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Effie","family":"Tsomos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Hammerstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.08.003_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2011.04.001","article-title":"The recent rise in the frequency of type 1 diabetes: who pulled the trigger?","volume":"37","author":"Hasham","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib4","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2337\/diabetes.51.12.3353","article-title":"The rise of childhood type 1 diabetes in the 20th century","volume":"51","author":"Gale","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2018.08.003_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcv.2017.09.003","article-title":"Type 1 diabetes and viral infections: what is the relationship?","volume":"96","author":"Principi","year":"2017","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.jaut.2018.08.003_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2004.01.008","article-title":"Interferon alpha--a potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity","volume":"111","author":"Devendra","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1359-6101(02)00088-6","article-title":"Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases","volume":"14","author":"Stewart","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jaut.2018.08.003_bib9","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1073\/pnas.1700878114","article-title":"Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-alpha signaling","volume":"114","author":"Marro","year":"2017","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib10","first-page":"280","article-title":"Virus interference: I. The interferon. By Alick Isaacs and Jean Lindenmann, 1957","volume":"38","year":"1988","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.jaut.2018.08.003_bib11","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1073\/pnas.1408821111","article-title":"Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity","volume":"111","author":"Stefan","year":"2014","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaut.2013.04.002","article-title":"Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways","volume":"44","author":"Hasham","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10067-004-1024-2","article-title":"Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C","volume":"24","author":"Niewold","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/1756-0500-6-437","article-title":"Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature","volume":"6","author":"Cacopardo","year":"2013","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.jaut.2018.08.003_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2017.02.002","article-title":"Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress","volume":"80","author":"Lombardi","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib16","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/labinvest.3700285","article-title":"Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis","volume":"85","author":"Takii","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jaut.2018.08.003_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2007.01610.x","article-title":"High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection","volume":"28","author":"Schreuder","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.08.003_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(94)90276-3","article-title":"Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia","volume":"343","author":"Guerci","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib20","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc10-2274","article-title":"Type 1 diabetes and interferon therapy: a nationwide survey in Japan","volume":"34","author":"Nakamura","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2018.08.003_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","article-title":"Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis","volume":"340","author":"Fabris","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4137\/CMED.S7815","article-title":"Type 1 diabetes mellitus associated with pegylated interferon-alpha plus ribavirin treatment for chronic hepatitis C: case report and literature review","volume":"4","author":"Oka","year":"2011","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/iub.1330","article-title":"Islet inflammation in human type 1 diabetes mellitus","volume":"66","author":"Morgan","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jaut.2018.08.003_bib24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/diab.44.6.658","article-title":"Interferon expression in the pancreases of patients with type I diabetes","volume":"44","author":"Huang","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib25","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(87)91128-7","article-title":"Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus","volume":"2","author":"Foulis","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib26","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.2337\/db16-0616","article-title":"Expression of interferon-stimulated genes in insulitic pancreatic islets of patients recently diagnosed with type 1 diabetes","volume":"65","author":"Lundberg","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cell.2016.06.024","article-title":"AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies","volume":"166","author":"Meyer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.08.003_bib28","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.08.003_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/db08-0964","article-title":"Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture","volume":"58","author":"Allen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib30","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1086\/315516","article-title":"Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection","volume":"181","author":"Chehadeh","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.08.003_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4049\/jimmunol.1303230","article-title":"Increased IFN-alpha-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-alpha production","volume":"193","author":"Xia","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib33","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/db13-1775","article-title":"Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility","volume":"63","author":"Kallionpaa","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib34","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2337\/db10-1269","article-title":"An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes","volume":"60","author":"Winkler","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00125-015-3843-x","article-title":"Blood-based signatures in type 1 diabetes","volume":"59","author":"Cabrera","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/gene.2009.112","article-title":"Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis","volume":"11","author":"Reynier","year":"2010","journal-title":"Gene Immun."},{"key":"10.1016\/j.jaut.2018.08.003_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/diab.40.2.255","article-title":"Altered expression of diabetes in BB\/Wor rats by exposure to viral pathogens","volume":"40","author":"Thomas","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2337\/diab.41.4.515","article-title":"Poly I:C induces development of diabetes mellitus in BB rat","volume":"41","author":"Sobel","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nm1176","article-title":"Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease","volume":"11","author":"Lang","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib41","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.8100367","article-title":"Induction of type I diabetes by interferon-alpha in transgenic mice","volume":"260","author":"Stewart","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.08.003_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/1074-7613(94)90089-2","article-title":"Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice","volume":"1","author":"Huang","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.08.003_bib43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.157.2.522","article-title":"IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2","volume":"157","author":"Chakrabarti","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib44","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2011.04.010","article-title":"The role of interferon alpha in initiation of type I diabetes in the NOD mouse","volume":"140","author":"Li","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nm.3042","article-title":"Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes","volume":"19","author":"Diana","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jaut.2001.0531","article-title":"Complete suppression of insulitis and diabetes in NOD mice lacking interferon regulatory factor-1","volume":"17","author":"Nakazawa","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-62703-068-7_3","article-title":"The BB rat as a model of human type 1 diabetes","volume":"933","author":"Bortell","year":"2012","journal-title":"Meth. Mol. Biol."},{"key":"10.1016\/j.jaut.2018.08.003_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1210\/en.2016-1609","article-title":"CD40 signaling in Graves disease is mediated through canonical and noncanonical thyroidal nuclear factor kappaB activation","volume":"158","author":"Lee","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2018.08.003_bib52","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1210\/en.2007-1024","article-title":"The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells","volume":"148","author":"McLachlan","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2018.08.003_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fendo.2016.00021","article-title":"Dissecting the genetic susceptibility to Graves' disease in a cohort of patients of Italian origin","volume":"7","author":"Lombardi","year":"2016","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jaut.2018.08.003_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF03346699","article-title":"Environmental triggers of thyroiditis: hepatitis C and interferon-alpha","volume":"34","author":"Menconi","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jaut.2018.08.003_bib55","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/jc.2004-1173","article-title":"Type I interferons modulate the expression of thyroid peroxidase, sodium\/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures","volume":"90","author":"Caraccio","year":"2005","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.jaut.2018.08.003_bib56","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-alpha mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/thy.2008.0290","article-title":"Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures","volume":"19","author":"Caraccio","year":"2009","journal-title":"Thyroid Off. J. Am. Thyroid Assoc."},{"key":"10.1016\/j.jaut.2018.08.003_bib58","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib59","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20161451","article-title":"Detection of interferon alpha protein reveals differential levels and cellular sources in disease","volume":"214","author":"Rodero","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib60","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"Lovgren","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.08.003_bib61","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1084\/jem.20132522","article-title":"Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"211","author":"Sisirak","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib62","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.39962","article-title":"Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus","volume":"69","author":"Furie","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jaut.1996.0015","article-title":"Molecular aspects and the pathological basis of primary biliary cirrhosis","volume":"9","author":"Leung","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib65","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib66","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00535-014-1033-0","article-title":"A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis","volume":"50","author":"Sasaki","year":"2015","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.08.003_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1572-0241.2001.03446.x","article-title":"Genetic and familial considerations of primary biliary cirrhosis","volume":"96","author":"Tanaka","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.08.003_bib68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2001.23902","article-title":"Molecular mimicry and primary biliary cirrhosis: premises not promises","volume":"33","author":"Van de Water","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib69","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib70","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF02806528","article-title":"Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients","volume":"27","author":"Morshed","year":"1992","journal-title":"Gastroenterol. Jpn."},{"key":"10.1016\/j.jaut.2018.08.003_bib71","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a betaretrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib72","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2010.12.009","article-title":"The evidence supports a viral aetiology for primary biliary cirrhosis","volume":"54","author":"Mason","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib73","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1478-3231.2005.01043.x","article-title":"Early development of primary biliary cirrhosis in female C57BL\/6 mice because of poly I:C administration","volume":"25","author":"Okada","year":"2005","journal-title":"Liver Int."},{"key":"10.1016\/j.jaut.2018.08.003_bib74","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.29524","article-title":"The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity","volume":"67","author":"Bae","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib75","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1111\/j.1572-0241.2000.02350.x","article-title":"Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy","volume":"95","author":"Yoshikawa","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.08.003_bib76","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/BF02065528","article-title":"Exacerbation of primary biliary cirrhosis during interferon-alpha 2b therapy for chronic active hepatitis C","volume":"40","author":"Maeda","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2018.08.003_bib77","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/BF02208992","article-title":"Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection","volume":"40","author":"D'Amico","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2018.08.003_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/PL00011206","article-title":"Rheumatoid arthritis induced by alpha-interferon therapy","volume":"20","author":"Passos de Souza","year":"2001","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib79","first-page":"28","article-title":"Rheumatoid arthritis probably induced by pegylated interferon in a patient with chronic hepatitis C","volume":"23","author":"Sood","year":"2004","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.08.003_bib80","first-page":"211","article-title":"Prolonged treatment with interferon alpha and peginterferon induces rheumatoid arthritis syndrome and erythema nodosum","volume":"17","author":"Ionescu","year":"2008","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.jaut.2018.08.003_bib81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib82","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/rheumatology\/kel346","article-title":"Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue","volume":"46","author":"Gattorno","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib83","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.08.003_bib84","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/ard.2007.086421","article-title":"Type I interferons might form the link between Toll-like receptor (TLR) 3\/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA)","volume":"68","author":"Roelofs","year":"2009","journal-title":"Ann. Rheum. Diseases"},{"key":"10.1016\/j.jaut.2018.08.003_bib85","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/08916930903510914","article-title":"The type I IFN system in rheumatoid arthritis","volume":"43","author":"Conigliaro","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2018.08.003_bib86","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/art.27226","article-title":"Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta\/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort","volume":"62","author":"Mavragani","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.08.003_bib87","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1002\/art.27702","article-title":"Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients","volume":"62","author":"Thurlings","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.08.003_bib88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/keu299","article-title":"Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy","volume":"54","author":"Wright","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib89","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5414\/CNP64163","article-title":"Relative hypoparathyroidism induced by interferon treatment in a hemodialysis patient","volume":"64","author":"Muray","year":"2005","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jaut.2018.08.003_bib90","first-page":"391","article-title":"Hypoparathyroidism during alpha-INF therapy in a patient with multiple myeloma","volume":"20","author":"Ueki","year":"1989","journal-title":"J. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib91","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2007.08.018","article-title":"Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease","volume":"133","author":"Di Sabatino","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.08.003_bib92","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)02880-4","article-title":"Onset of coeliac disease during treatment with interferon for chronic hepatitis C","volume":"356","author":"Cammarota","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.08.003_bib93","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.48.3.425","article-title":"Role of interferon alpha in promoting T helper cell type 1 responses in the small intestine in coeliac disease","volume":"48","author":"Monteleone","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2018.08.003_bib94","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/CND.0b013e318285257f","article-title":"Pegylated interferon induced myasthenia crisis--a case report","volume":"14","author":"Congeni","year":"2013","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jaut.2018.08.003_bib95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/10799900152434321","article-title":"Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C","volume":"21","author":"Borgia","year":"2001","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2018.08.003_bib96","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/pde.13418","article-title":"Interferon-alpha induced psoriasis in a teenager","volume":"35","author":"Mendieta","year":"2018","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib97","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/1346-8138.12234","article-title":"Vitiligo after combination therapy of pegylated interferon-alpha-2a, ribavirin and vitamin D in a patient with chronic hepatitis C","volume":"40","author":"Oiso","year":"2013","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.0736-8046.2004.21512.x","article-title":"Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection","volume":"21","author":"Seckin","year":"2004","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib99","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2004.10.029","article-title":"Occurrence of porphyria cutanea tarda during peginterferon\/ribavirin therapy for chronic viral hepatitis C","volume":"42","author":"Thevenot","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.06.2011.4400","article-title":"Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient","volume":"2011","author":"Said","year":"2011","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jaut.2018.08.003_bib101","first-page":"ECR26","article-title":"Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin","volume":"91","author":"Cauli","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2018.08.003_bib102","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","article-title":"A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients","volume":"73","author":"Higgs","year":"2014","journal-title":"Ann. Rheum. Diseases"},{"key":"10.1016\/j.jaut.2018.08.003_bib103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000346244","article-title":"Two cases of interferon-alpha-induced sarcoidosis Koebnerized along venous drainage lines: new pathogenic insights and review of the literature of interferon-induced sarcoidosis","volume":"226","author":"Buss","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaut.2018.08.003_bib104","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/jamaophthalmol.2014.198","article-title":"Cotton-wool spots and retinal hemorrhages. Interferon-associated retinopathy","volume":"132","author":"Andreoli","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jaut.2018.08.003_bib105","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proceed. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.08.003_bib106","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.2337\/db07-1023","article-title":"Viral trigger for type 1 diabetes: pros and cons","volume":"57","author":"Filippi","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2002.tb02943.x","article-title":"Viruses and diabetes","volume":"958","author":"Jaeckel","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2018.08.003_bib108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0950-351X(95)80819-1","article-title":"Infections and autoimmune endocrine disease","volume":"9","author":"Tomer","year":"1995","journal-title":"Bailliere. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.jaut.2018.08.003_bib109","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/pedi.12547","article-title":"Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk","volume":"19","author":"Mustonen","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib110","doi-asserted-by":"crossref","first-page":"d35","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.jaut.2018.08.003_bib111","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00125-012-2745-4","article-title":"Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1","volume":"56","author":"Richardson","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib112","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-016-4177-z","article-title":"Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity","volume":"60","author":"Honkanen","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib113","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/jmv.21008","article-title":"Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method","volume":"79","author":"Elfaitouri","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2018.08.003_bib114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/vim.2009.0072","article-title":"Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection","volume":"23","author":"Schulte","year":"2010","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib115","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","article-title":"Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib116","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2016-000219","article-title":"Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes","volume":"4","author":"Hodik","year":"2016","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.jaut.2018.08.003_bib117","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1096\/fj.06-7905com","article-title":"Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection","volume":"21","author":"Zanone","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.jaut.2018.08.003_bib118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12985-017-0905-3","article-title":"A preliminary analysis of hepatitis C virus in pancreatic islet cells","volume":"14","author":"Blackard","year":"2017","journal-title":"Virol. J."},{"key":"10.1016\/j.jaut.2018.08.003_bib119","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.autrev.2016.07.019","article-title":"The viral paradigm in type 1 diabetes: who are the main suspects?","volume":"15","author":"Rodriguez-Calvo","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2018.08.003_bib120","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/jmv.23835","article-title":"Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway","volume":"86","author":"Anagandula","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2018.08.003_bib121","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/db14-1020","article-title":"Viral infection of engrafted human islets leads to diabetes","volume":"64","author":"Gallagher","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib122","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.08.003_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib124","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diab.45.10.1336","article-title":"Control of islet intercellular adhesion molecule-1 expression by interferon-alpha and hypoxia","volume":"45","author":"Chakrabarti","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1471-4906(02)02195-6","article-title":"Cytokines as a link between innate and adaptive antitumor immunity","volume":"23","author":"Belardelli","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib126","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1126\/science.1074900","article-title":"Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection","volume":"297","author":"Nguyen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.08.003_bib127","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04082","article-title":"Mechanism of action of interferon and ribavirin in treatment of hepatitis C","volume":"436","author":"Feld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.08.003_bib128","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4049\/jimmunol.167.3.1179","article-title":"IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation","volume":"167","author":"Mattei","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib129","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib130","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V99.9.3263","article-title":"Type I interferons produced by dendritic cells promote their phenotypic and functional activation","volume":"99","author":"Montoya","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2018.08.003_bib131","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferon in vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.08.003_bib132","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri2215","article-title":"How dying cells alert the immune system to danger","volume":"8","author":"Kono","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib133","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.20101692","article-title":"Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay","volume":"208","author":"Diana","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2008.12.017","article-title":"NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner","volume":"30","author":"Diana","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.08.003_bib135","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.2337\/db11-0700","article-title":"To B or not to B: (anti)bodies of evidence on the crime scene of type 1 diabetes?","volume":"60","author":"Mallone","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib136","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4049\/jimmunol.1102176","article-title":"Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant","volume":"188","author":"Habib","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib137","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0002-9343(03)00390-5","article-title":"Autoimmune aspects of cytokine and anticytokine therapies","volume":"115","author":"Krause","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2018.08.003_bib138","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999000750053690","article-title":"Biologic responses to IFN-alpha administration in humans","volume":"20","author":"Corssmit","year":"2000","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2018.08.003_bib139","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri3247","article-title":"Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination","volume":"12","author":"Desmet","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib140","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/endo-117-5-2081","article-title":"Inhibitory effect of interferon on the production of insulin","volume":"117","author":"Shimizu","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2018.08.003_bib141","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF00276977","article-title":"Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets","volume":"27","author":"Rhodes","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib142","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/jc.2014-2745","article-title":"Endoplasmic reticulum stress as a novel mechanism in amiodarone-induced destructive thyroiditis","volume":"100","author":"Lombardi","year":"2015","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.jaut.2018.08.003_bib143","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib144","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diab.38.7.815","article-title":"MHC molecules and beta-cell destruction. Immune and nonimmune mechanisms","volume":"38","author":"Harrison","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib145","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/cti.2016.26","article-title":"Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway","volume":"5","author":"Oon","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jaut.2018.08.003_bib146","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-017-0203-0","article-title":"Impaired mitochondrial calcium uptake caused by tacrolimus underlies beta-cell failure","volume":"15","author":"Lombardi","year":"2017","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.jaut.2018.08.003_bib147","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1038\/s41598-017-15283-y","article-title":"Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells","volume":"7","author":"Lombardi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.08.003_bib148","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1002\/j.1460-2075.1990.tb07879.x","article-title":"Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses","volume":"9","author":"Shan","year":"1990","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2018.08.003_bib149","doi-asserted-by":"crossref","first-page":"13184","DOI":"10.1074\/jbc.271.22.13184","article-title":"Inhibition of mitochondrial function by interferon","volume":"271","author":"Lewis","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2018.08.003_bib150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1469-7793.2000.00049.x","article-title":"Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell","volume":"529 Pt","author":"Maechler","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.jaut.2018.08.003_bib151","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/107999000750053799","article-title":"Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells","volume":"20","author":"Yanase","year":"2000","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.jaut.2018.08.003_bib152","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.onc.1201745","article-title":"Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages","volume":"16","author":"Matsuoka","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.jaut.2018.08.003_bib153","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diab.38.5.641","article-title":"Effect of interferon on glucose tolerance and insulin sensitivity","volume":"38","author":"Koivisto","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib154","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1096-9136(199704)14:4<327::AID-DIA315>3.0.CO;2-6","article-title":"The role of insulin resistance in the natural history of type 1 diabetes","volume":"14","author":"Leslie","year":"1997","journal-title":"Diabet. Med. J. Br. Diabetic Assoc."},{"key":"10.1016\/j.jaut.2018.08.003_bib155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2013.10.001","article-title":"DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology","volume":"50","author":"Stefan","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2018.08.003_bib156","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature07336","article-title":"Innate immunity and intestinal microbiota in the development of Type 1 diabetes","volume":"455","author":"Wen","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.08.003_bib157","doi-asserted-by":"crossref","first-page":"31168","DOI":"10.1074\/jbc.M111.247510","article-title":"Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism","volume":"286","author":"Stefan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2018.08.003_bib158","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2337\/db11-0729","article-title":"Cesarean section and interferon-induced helicase gene polymorphisms combine to increase childhood type 1 diabetes risk","volume":"60","author":"Bonifacio","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2018.08.003_bib159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1152\/physiolgenomics.00001.2013","article-title":"RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles","volume":"45","author":"Miao","year":"2013","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.jaut.2018.08.003_bib160","first-page":"21","article-title":"The importance of the type I interferon system in autoimmunity","volume":"34","author":"Ronnblom","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2018.08.003_bib161","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/annrheumdis-2015-208562","article-title":"Sifalimumab, an anti-interferon-alpha monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study","volume":"75","author":"Khamashta","year":"2016","journal-title":"Ann. Rheum. Diseases"},{"key":"10.1016\/j.jaut.2018.08.003_bib162","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.37785","article-title":"Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon alpha-kinoid","volume":"65","author":"Lauwerys","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2018.08.003_bib163","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00125-014-3436-0","article-title":"A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models","volume":"58","author":"Larsson","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2018.08.003_bib164","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jmv.21476","article-title":"Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion","volume":"81","author":"Moell","year":"2009","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jaut.2018.08.003_bib165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2006.12.001","article-title":"Antiviral treatment of Coxsackie B virus infection in human pancreatic islets","volume":"74","author":"Berg","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jaut.2018.08.003_bib166","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2015.01.010","article-title":"Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine","volume":"116","author":"Alidjinou","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118303238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118303238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:21:04Z","timestamp":1760257264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118303238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":166,"alternative-id":["S0896841118303238"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.08.003","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon alpha: The key trigger of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}